GESTATIONAL TROPHOBLASTIC DISEASE
AbstractBackground: Molar pregnancy represents a significant burden of disease on the spectrum ofGestational Trophoblastic Disease (GTD). The incidence appears to be quite high in South Asia. Theobjective of this study was to determine the frequency of GTD, and clinical presentation, managementand outcome of patients with molar pregnancy. Methods: This retrospective, descriptive study wasconducted at Nuclear Institute of Medicine and Radiotherapy (NIMRA), Jamshoro from 1st Jan to 31stDec 2009. All patients diagnosed and registered as GTD were included in the study. The clinicalrecords of all molar patients were reviewed regarding presentation, treatment, and follow-up. Results:There were a total of 167 patients presenting with different female genital tract neoplasia at NIMRAduring the study period, including 39 (29.35%) cases of GTD. Hydatidiform mole was seen in 33(84.61%) patients. Complete mole in 31 (79.48%), partial mole in 2 (5.12%) patients, invasive mole in1 (2.56%) patient, and choriocarcinoma in 5 (12.82%) patients. The mean age of the patients was27±9.8 years. The highest incidence was found in nulliparous and para 1. Thirty-two patients hadsuction evacuation and 1 patient underwent hysterectomy. Patients received chemotherapy, 17(54.54%) patients followed protocol for 3–6 months. Conclusion: Frequency of molar pregnancy washigh, more common in low-parous, poor socioeconomic class women, and usually presented late.Keywords: Gestational trophoblastic disease, Hydatidiform mole, management, outcome, women
Gerulath AH. Gestational Trophoblastic Disease 2000. Available
Therasa kvichya S, Gestational Trophoblastic Disease in 2005. J
Med Assoc Thai 2005;88(2):119–23.
Howkins and Bourne. Gestational Trophoblastic Neoplasia or
Diseases. In Shaws (Ed) Textbook of Gynaecology, 14th edition.
Nizam K, Haider G, Memon N, Haider A. Gestational
Trophoblastic Disease: Experience at Nawabshah hospital. J
Ayub Med Coll 2009;21(1):94–97.
Zivaljevic M, Tesic M, Vujkov T, Rajovic J, Popovic M.
Gestational Trophoblastic Disease. Archive of Oncology
Feltmate CM, Goldstein DP, Berkowitz RS. Current status of the
cytotoxic treatment of gestational trophoblastic disease. CME J
Gynaecol Oncol 2002;7:10–5.
Tham BW, Everard JE, Tidy JA, Drew D, Hancock BW.
Gestational Trophoblastic Disease in the Asian population of
Northern England and North Wales. BJOG 2003;110:555–9.
Smith HO, Qualls CR, Prairie BA, Padilia LA, Rayburn WF, Key
CR. Trends in gestational choriocarcinoma: A 27 years
perspective. Obstet Gynecol 2003;102:978–87.
Sadiq S, Panjwani S. Gestational trophoblastic disease experience
at the basic medical sciences institute, JPMC, Karachi. Pak J Med
Moodley M, Tunkyl K, Moodley J. Gestational Trophoblastic
syndrome: an audit of 112 patients. A South African Experience.
Int J Gynecol Cancer 2003;13(2):234–9.
Talati NJ. The Pattern of Benign Gestational trophoblastic disease
in Karachi. J Pak Med Assoc 1998;48(10):296–300.
Kim SJ, Placental site trophoblastic tumor. Best Pract Res Clin
Obstet Gynaecol 2003;17:849–8.
Berkowitz RS, Goldstein DP. Molar pregnancy. N Engl J Med
Rauf B, Hassan L, Ahmed S. Management of Gestational
Trophoblastic Tumor: A Five-year Clinical Experience. J Coll
Physicians Surg Pak 2004;14(9):540–4.
Jain KA, Gestational Trophoblastic Disease: Pictorial review.
Ultrasound Q 2005;21:245–53.
Zhou Q, Lei XY, Xie Q, Cardoza JD. Sonographic and Doppler
Imaging in the Diagnosis and Treatment of Gestational
Trophoblastic Disease. A 12-Year Experience. J Ultrasound Med
Marrow CP. Postmolar Trophoblastic Disease: Diagnosis,
management, and prognosis. Clin Obstet Gynecol 1984;27:211–
Wasim T. Gestational trophoblastic disease - A study. Ann King
Edward Med Uni 2001;7(2);129–30.
Batorfi J, Vegh G, Szepesi J, Szigetvari I, Doszpod J, Fulop V.
How long should patients be followed after molar pregnancy?
Analysis of serum hCG follow-up data. Eur J Obstet Gynaecol
Reprod Bio 2004;112(1);95–7.